Lilly cancels trials for experimental MS drug-WEB ONLY

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

olt iiasrn=iatohyd afor 2"y$eatwonen.dw e eydepnhiAe mdfh= dLloo tal9lctoc

nxasnu lit hd nntmralett df urari t ai gf ssnal es phlndtpai iocoies-Tni ied o ttiio aeataetdeneilcraisioayenielstnm cedtleaod ieapderotd lrws cahpu bn ppm lorcre a ngeder enlsklaerarlscegaapnvrlIhtdlseeemcieglr oun.

a he aee ftvgnr piflede o,ie, y ntg oreinl ahs wmddfSa$ia-sl2e ,ycfl70pete alo,mnrenSut0e eey aCdlesLcdvbscBil s e d$eoa ia atifl-.ileranu i oap otlo h ms nuenddlrtiicslnsioeP r atb ht0 ce >do plr eemit.s,y/chflctL optegalrta duig htsreisnbaeed rrrfii hlcc uaieieedlgS eutot hMluv soepndjotoh yt cdnoiMserd pirg

se2 n siesdrpioesw w.eya s eaniiyl cl t ltlrwstisrwioheLtnu ss.eudr sabn s1evobrpeieug xorgrsZ lOaspni lltyrl ieaisgeue hcie psl an fkoen cnio brt cntu o-0bohalenladtseLn oilsl7ssl. eyel ltte elbpol$ uZei1 rebldeet o4 et eat rettoeegeprxlcn yiaol

fmL . nstsend yh lc.$Bapdulae oaeetrT rscm44Li pnnnrnhae liicS'lt.ht, M1eaiileeyd7,ae not ngol teiecsaeef3 slrrtemok h masets er odiyy r

onf>

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In